Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Abroad (travel likely)RecruitingPHASE3

Conditions

Tuberculous Meningitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cocody University Hospital, Abidjan, Côte d’Ivoire

    Contact: Study coordinator (Horo Kigninlman, Prof)
  • Treichville University Hospital, Abidjan, Côte d’Ivoire

    Contact: Study coordinator (Gisèle Kouakou, Prof.)
  • Yopougon University Hospital, Abidjan, Côte d’Ivoire

    Contact: Study coordinator (Thierry Odehoury-Koudou, Prof)
  • University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar

    Contact: Study coordinator (Mamy Jean de Dieu Randria, Prof.)
  • University Hospital Tambohobe, Fianarantsoa, Madagascar

    Contact: Study coordinator (Rivonirina Andry Rakotoarivelo, Prof.)
  • Morafeno University Hospital, Toamasina, Madagascar

    Contact: Study coordinator (Stéphane Dimby Ralandison, Prof)
  • Kayelitsha District Hospital, Cape Town, South Africa

    Contact: Study coordinator (Graeme Meintjes, Prof.)
  • Mitchells Plain Hospital, Cape Town, South Africa

    Contact: Study coordinator (Graeme Meintjes, Prof.)
  • New Somerset Hospital, Cape Town, South Africa

    Contact: Study coordinator (Sean Wassermann, Dr)
  • Dora Nginza Hospital, Port Elizabeth, South Africa

    Contact: Study coordinator (Nowshad Alam, Dr)
  • Livingstone and PE Central Hospitals, Port Elizabeth, South Africa

    Contact: Study coordinator (John Black, Dr.)
  • Mbarara Regional Reference Hospital, Mbarara, Uganda

    Contact: Study coordinator (Conrad Muzoora, Dr.)
  • Regional Reference Hospital of Kabale, Mbarara, Uganda

    Contact: Study coordinator (Marion Namutebi, Dr.)
Study leads
  • Fabrice Bonnet, M.D., Ph.D.

    Principal Investigator

    University Hospital, Bordeaux